board of directors
- management team
- board of directors
- founders
- investors
Robert Connelly Chief Executive Officer
David A. Edwards, Ph.D. Professor of Biomedical Engineering, Harvard University
Steven Gillis, Ph.D. Managing Director, ARCH Venture Partners
David Maki General Partner, Altitude Life Sciences Ventures
Terry McGuire Co-Founder and Managing Partner, Polaris Venture Partners
Scott Rocklage, Ph.D. Managing Partner, 5AM Ventures
Lauren Silverman, Ph.D. Managing Director, Novartis Option Fund
Prior to joining the Option Fund, Lauren was Global Head of Oncology Research Operations for Novartis. Previously, Lauren spent much of her career in Licensing & Business Development, first at OSI Pharmaceuticals and later at Pfizer with responsibilities in the areas of CNS, ophthalmology and oncology. Lauren was also a Director of Strategic Alliances and Head of Cell Biology after having been a founding scientist of Cadus Pharmaceuticals. Lauren was a postdoctoral fellow at Memorial Sloan Kettering Cancer Center and Princeton University and earned her Ph.D. in molecular biology from the University of Utah. She is the author of 12 scientific publications and 4 patents.